Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen Increases Sales but Misses Estimates on Earnings
Motley Fool
Saturday, January 28, 2012 - 11:30am
tags:
Amgen
Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.
Yahoo/BusinessWire
Saturday, January 28, 2012 - 11:29am
tags:
Micromet, Amgen, M&A, lawsuits
2 Biotech Acquisitions in 1 Day! Let's Throw a Party
Motley Fool
Saturday, January 28, 2012 - 11:28am
tags:
Amgen, Micromet, M&A, Celgene, Avila
Pacific Biosciences of California, Inc. 4th Quarter and Fiscal Year 2011 Financial Results Call
Yahoo/Globe NewsWire
Saturday, January 28, 2012 - 11:26am
tags:
Pacific Biosciences
The Law Firm of Weiss & Lurie Investigates Micromet, Inc.
Yahoo/BusinessWire
Saturday, January 28, 2012 - 11:25am
tags:
Micromet, Amgen, M&A, lawsuits
The Law Firm of Weiss & Lurie Investigates Illumina Inc.
Yahoo/BusinessWire
Saturday, January 28, 2012 - 11:24am
tags:
Illumina, Roche, M&A, lawsuits
Cramer's Favorite Healthcare Play - Sanofi (video)
CNBC
Saturday, January 28, 2012 - 11:23am
tags:
Sanofi
10 Health Care Stocks to Watch
The Street
Saturday, January 28, 2012 - 11:21am
tags:
Alexion, Gilead Sciences, Biogen Idec, Amgen, Becton Dickinson, Celgene, Intuitive Surgical, Eli Lilly, St. Jude Medical, Stryker
Bionovo to Voluntarily Delist from NASDAQ
Yahoo/PR NewsWire
Saturday, January 28, 2012 - 11:17am
tags:
Bionovo
Amylin, Alkermes Long-Acting Diabetes Drug Wins FDA Approval on Third Try
Bloomberg
Friday, January 27, 2012 - 3:12pm
tags:
Amylin, FDA, Alkermes, diabetes, Bydureon
Infinity stops cancer drug trial, shares dive
Reuters
Friday, January 27, 2012 - 12:18pm
tags:
Infinity Pharma, saridegib
Nexium, Actos, or Diovan? Analysts try to ID Ranbaxy's 3 sacrifices
Fierce Pharma
Friday, January 27, 2012 - 12:17pm
tags:
Nexium, Actos, Diovan, Ranbaxy
Another Catalyst For Protalix BioTherapeutics
Seeking Alpha
Friday, January 27, 2012 - 12:15pm
tags:
Protalix BioTherapeutics
Earnings Preview For Pfizer Q4 2011
Seeking Alpha
Friday, January 27, 2012 - 12:14pm
tags:
earnings, Pfizer
ImmunoGen fiscal 2Q loss shrinks on milestone pay
Yahoo/AP
Friday, January 27, 2012 - 11:33am
tags:
earnings, Immunogen
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Seeking Alpha
Friday, January 27, 2012 - 11:08am
tags:
Alexion, Amgen, Ariad, Biogen Idec, Bristol-Myers Squibb, Celgene, Gilead, Illumina, Inhibitex, Vertex Pharmaceuticals
Roche Begins $5.7 Billion Hostile Takeover Offer for Gene Mapper Illumina
Bloomberg
Friday, January 27, 2012 - 11:03am
tags:
Roche, hostile takeover, Illumina
Amgen Misses Fourth-Quarter Profit Estimates as Anemia Drug Sales Tumble
Bloomberg
Friday, January 27, 2012 - 10:35am
tags:
Amgen, earnings
Johnson & Johnson Wins Jury Verdict Over Levaquin Warning
Bloomberg
Friday, January 27, 2012 - 10:32am
tags:
JNJ, Levaquin, warnings
Pfizer Sued By Employees Over Retirement Plans
Pharmalot
Friday, January 27, 2012 - 10:31am
tags:
retirement, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.